DCM
CRL icon

Davidson Capital Management’s Charles River Laboratories CRL Stock Holding History

Davidson Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32
Closed -$8.67K – 85
2024
Q1 		$8.67K Buy
32
+4
+14% +$955 ﹤0.01% 69
2023
Q4 		$6.62K Hold
28
– – ﹤0.01% 93
2023
Q3 		$5.49K Buy
28
+11
+65% +$2.26K ﹤0.01% 61
2023
Q2 		$3.58K Buy
17
+1
+6% +$199 ﹤0.01% 80
2023
Q1 		$3.23K Buy
16
+3
+23% +$680 ﹤0.01% 81
2022
Q4 		$2.83K Sell
13
-51
-80% -$11.1K ﹤0.01% 90
2022
Q3 		$13K Sell
64
-4,133
-98% -$892K 0.01% 42
2022
Q2 		$898K Buy
4,197
+20
+0.5% +$4.89K 0.42% 32
2022
Q1 		$1.19M Buy
4,177
+724
+21% +$223K 0.44% 49
2021
Q4 		$1.3M Buy
3,453
+221
+7% +$85.9K 0.71% 56
2021
Q3 		$1.33M Sell
3,232
-593
-16% -$246K 0.67% 22
2021
Q2 		$1.42M Sell
3,825
-459
-11% -$153K 0.68% 15
2021
Q1 		$1.24M Buy
4,284
+640
+18% +$178K 0.65% 20
2020
Q4 		$910K Buy
3,644
+101
+3% +$24.1K 0.51% 43
2020
Q3 		$802K Sell
3,543
-935
-21% -$194K 0.51% 35
2020
Q2 		$781K Buy
4,478
+275
+7% +$43.9K 0.69% 37
2020
Q1 		$530K Buy
+4,203
New +$630K 0.76% 37

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Davidson Capital Management's CRL Position: Q2 2024 in Review

Davidson Capital Management sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 32 shares — an estimated $8.67K sold.

Davidson Capital Management first reported a position in CRL in Q1 2020 and held it in 17 quarters. The position peaked at $1.42M in Q2 2021. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Davidson Capital Management reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Davidson Capital Management sold 32 Charles River Laboratories shares in Q2 2024, an estimated $8.67K.
  • Davidson Capital Management first reported a position in Charles River Laboratories in Q1 2020 and held it in 17 quarters.
  • Davidson Capital Management's Charles River Laboratories position peaked at $1.42M in Q2 2021.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Davidson Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.